Literature DB >> 17919735

Evaluation of corticospinal axon loss by fluorescent dye tracing in mice with experimental autoimmune encephalomyelitis.

Zhongwu Liu1, Yi Li, Jing Zhang, Stanton Elias, Michael Chopp.   

Abstract

In both multiple sclerosis (MS) patients and experimental autoimmune encephalomyelitis (EAE) animals, axon loss has been demonstrated to correlate with neurological disability. However, it is difficult to accurately determine the location and severity of axonal damage since the lesion in MS or EAE is disseminated and is frequently in a relapsing-remitting mode. The corticospinal system is the only direct pathway from the motorsensory cortex to the spinal cord, and the major neural pathway for control of voluntary movement. Moreover, it is frequently involved in the pathological process of the disease. To evaluate corticospinal tract (CST) axon loss in EAE mice, we developed a direct tracing method with a fluorescent neuronal tracer DiI which was injected into the primary motor cortex and sensorimotor cortex to label the pyramidal neurons. The lesion location in the spinal cord and axon disruption were indicated by dye leakage. Using the EAE induced axon reduction as an index of the extent of axonal damage, our data showed a high correlation between the axonal loss and the behavioral outcome score in the EAE mice. The results were consistent with the axonal Bielschowsky silver staining. Thus, this CST tracing method permits monitoring of the axonal damage in EAE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17919735      PMCID: PMC2265634          DOI: 10.1016/j.jneumeth.2007.08.013

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  36 in total

1.  New temperature modification makes the Bielschowsky silver stain reproducible.

Authors:  S Litchfield; Z Nagy
Journal:  Acta Neuropathol       Date:  2001-01       Impact factor: 17.088

2.  A novel method for simultaneous anterograde and retrograde labeling of spinal cord motor tracts in the same animal.

Authors:  E C Tsai; R L van Bendegem; S W Hwang; C H Tator
Journal:  J Histochem Cytochem       Date:  2001-09       Impact factor: 2.479

Review 3.  Animal models for autoimmune demyelinating disorders of the nervous system.

Authors:  R Gold; H P Hartung; K V Toyka
Journal:  Mol Med Today       Date:  2000-02

4.  Demyelination and axonal damage in a non-human primate model of multiple sclerosis.

Authors:  G Mancardi; B Hart; L Roccatagliata; H Brok; D Giunti; R Bontrop; L Massacesi; E Capello; A Uccelli
Journal:  J Neurol Sci       Date:  2001-02-15       Impact factor: 3.181

5.  Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.

Authors:  Jerome R Wujek; Carl Bjartmar; Edward Richer; Richard M Ransohoff; Min Yu; Vincent K Tuohy; Bruce D Trapp
Journal:  J Neuropathol Exp Neurol       Date:  2002-01       Impact factor: 3.685

6.  Synapse formation during neuron differentiation: an in situ study of the myenteric plexus during murine embryonic life.

Authors:  M G Vannucchi; M S Faussone-Pellegrini
Journal:  J Comp Neurol       Date:  2000-09-25       Impact factor: 3.215

7.  Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.

Authors:  C Bjartmar; G Kidd; S Mörk; R Rudick; B D Trapp
Journal:  Ann Neurol       Date:  2000-12       Impact factor: 10.422

8.  Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.

Authors:  B Kornek; M K Storch; R Weissert; E Wallstroem; A Stefferl; T Olsson; C Linington; M Schmidbauer; H Lassmann
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

9.  Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.

Authors:  Tanja Kuhlmann; Gueanelle Lingfeld; Andreas Bitsch; Jana Schuchardt; Wolfgang Brück
Journal:  Brain       Date:  2002-10       Impact factor: 13.501

10.  Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability.

Authors:  J H van Waesberghe; W Kamphorst; C J De Groot; M A van Walderveen; J A Castelijns; R Ravid; G J Lycklama à Nijeholt; P van der Valk; C H Polman; A J Thompson; F Barkhof
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

View more
  6 in total

1.  Neuronopathy in the motor neocortex in a chronic model of multiple sclerosis.

Authors:  Travis Burns; Laird Miers; Jie Xu; Alan Man; Monica Moreno; David Pleasure; Peter Bannerman
Journal:  J Neuropathol Exp Neurol       Date:  2014-04       Impact factor: 3.685

2.  Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.

Authors:  Athena M Soulika; Eunyoung Lee; Erica McCauley; Laird Miers; Peter Bannerman; David Pleasure
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

3.  MiR-17-92 enriched exosomes derived from multipotent mesenchymal stromal cells enhance axon-myelin remodeling and motor electrophysiological recovery after stroke.

Authors:  Hongqi Xin; Zhongwu Liu; Benjamin Buller; Yanfeng Li; William Golembieski; Xinling Gan; Fengjie Wang; Mei Lu; Meser M Ali; Zheng G Zhang; Michael Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2020-08-18       Impact factor: 6.200

4.  Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neurorestorative cell-based therapies.

Authors:  Michael Chopp; Yi Li; Zheng Gang Zhang
Journal:  Stroke       Date:  2008-12-08       Impact factor: 7.914

5.  Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.

Authors:  Daniel K Crawford; Mario Mangiardi; Bingbing Song; Rhusheet Patel; Sienmi Du; Michael V Sofroniew; Rhonda R Voskuhl; Seema K Tiwari-Woodruff
Journal:  Brain       Date:  2010-09-21       Impact factor: 13.501

6.  Comprehensive catwalk gait analysis in a chronic model of multiple sclerosis subjected to treadmill exercise training.

Authors:  Danielle Bernardes; Alexandre Leite Rodrigues Oliveira
Journal:  BMC Neurol       Date:  2017-08-22       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.